References
- de Hoog GAS, Guarro J, Gene J, Figueras MJ. Atlas Of Clinical Fungi, 2nd edn. Utrecht, The Netherlands: Centraalbureau voor Schimmelcultures, 2001. © 2003 SHAM, Medical Mycology 41, 253–258
- Castro LGM, Salebian A, Sotto MN. Hyalohyphomycosis by Paecilomyces lilacinus in a renal transplant patient and a review of human Paecilomyces species infections. J Med Vet Mycol 1990; 28: 15–26.
- Orth B, Frei R, Itin PH, et al. Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann Intern Med 1996; 125: 799-806. 4 Itin PH, Frei R, Lautenschlager S, et al. Cutaneous manifesta-tions of Paecilomyces lilacinus infection induced by a contami-nated skin lotion in patients who are severely immunosuppressed. J Am Acad Dermatol 1998; 39: 401–409.
- Hecker MS, Weinberg JM, Bagheri B, et al. Cutaneous Paecilo-myces lilacinus infection: report of two novel cases. J Am Acad Dermatol 1997; 37: 270–271.
- Castro LG. Cutaneous Paecilomyces lilacinus infection. J Am Acad Dermatol 1998; 39: 516–517.
- Fletcher CL, Hay RJ, Midgley G, Moore M. Onychomycosis caused by infection with Paecilomyces lilacinus. Br J Dermatol 1998; 139: 1133–1135.
- Clark NM. Paecilomyces lilacinus infection in a heart transplant recipient and successful treatment with terbinafine. Clin Infect Dis 1999; 28: 1169–1170.
- Gutierrez-Rodero F, Morganon M, Ortiz de la Tabla V, Mayoll MI Martin C. Cutaneous hyalohyphomycosis caused by Paecilo-myces lilacinus in an immunocompetent host successfully treated with itraconazole: case report and review Eur J Clin Microbiol Infect Dis 1999; 18: 814–818.
- Hilmarsdottir I, Thorsteinsson SB, Asmundsson P, Bodvarsson M, Arnadottir M. Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voricona-zole. Scand J Infect Dis 2000; 32: 331–332.
- Blackwell V, Ahmed K, Docherty CO, Hay RI Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in a renal transplant patient. Br J Dermatol 2000; 143: 873–875.
- Gottlieb T, Atkins BL. Case report. Successful treatment of cutaneous Paecilomyces lilacinus infection with oral itraconazole in an immune competent host. Mycoses 2001; 44: 513–515.
- Safdar A. Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: rapid response to treatment with caspo-fungin and itraconazole. Clin Infect Dis 2002; 34: 1415–1417.
- Gucalp R, Carlisle P, Gialanella P, Mitsudo S, McKitrick J, Dutcher J. Paecilomyces sinusitis in an immunocompromised adult patient: case report and review Clin Infect Dis 1996; 23: 391 —393.
- Saberhagen C, Klotz SA, Bartholomew W, Drews D, Dixon A. Infection due to Paecilomyces lilacinus: A challenging clinical identification. Clin Infect Dis 1997; 25: 1411–1413.
- Chan-Tack KM, Thio CL, Miller NS, Karp CL, Ho C, Merz WG. Paecilomyces lilacinus fungemia in an adult bone marrow transplant recipient. Med Mycol 1999; 37: 57–60.
- Scott IU, Flynn Jr. HW, Miller D, Speights JW, Snip RC, Brod RD. Exogenous endophthalmitis caused by amphotericin B-resistant Paecilomyces lilacinus: treatment options and visual outcomes. Arch Ophthalmol 2001; 119: 916–919.
- Tan TQ, Ogden AK, Tillman J, Demmler GJ, Rinaldi MG. Paecilomyces lilacinus catheder-related fungemia in an immuno-compromised pediatric patient. J Clin Microbiol 1992; 30: 2479–2483.
- Westenfeld F, Alston WK, Winn WC. Complicated soft tissue infection with prepatellar bursitis caused by Paecilomyces lilacinus in an immunocompetent host: case report and review. J Clin Microbiol 1996; 34: 1559–1562.
- Espinel-Ingroff A. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic fungi. J Clin Microbiol 2001; 39: 1360–1367.
- Szekely A, Johnson EM, Warnock DW. Comparison of E-tests and broth microdilution methods for antifungal drug suscept-ibility testing of molds. J Clin. Microbiol 1999; 37: 1480–1483.
- Liu K, Howell DN, Perfect JR, Schell WA. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces and Acremonium species by histopathology. Am J Clin Pathol 1998; 109: 45–54.
- Kac G, Piriou P, :who E, Roux P, Trémoulet J, Denis M, Judet T. Osteoarthritis caused by Neocosmospora vasinfecta. Med Mycol 1999; 37: 213–217.
- Kurzai 0, El Barkani A, Mühlschlegel FA. Adaptation of fungi to alterations of the environmental ph. In: Calderone R, Cihlar R (eds). Fungal Pathogenesis — Principles and Clinical Applications. New York: Marcel Dekker, 2001: 139–160.
- Kurzai 0, Heinz WJ, Milhlschlegel FA. ASM Conference: Candida and Candidiasis. Mycoses 1999; 42: 427–430.
- Espinel-Ingroff A. In vitro fungicidal activities of voriconazole, itraconazole and amphotericin B against opportunistic moniliac-eous and dematiaceous fungi. J Clin Microbiol 2001; 39: 954–958.
- Garbino J, Ondrusova A, Baligvo E, Lew D, Bouchuiguir-Wafa K, Rohner P. Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole. Scand J Infect Dis 2002; 34: 701 —703.
- Martin CA, Roberts S, Greenberg RN. Voriconazole treatment of disseminated Paecilomyces lilacinus infection in a patient with Acquired Immunodeficiency Syndrome. Clin Inf Dis 2002; 35: 78–81.